Utah Medical Products
UTMD
74 hedge funds and large institutions have $182M invested in Utah Medical Products in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 4 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 22
2% more capital invested
Capital invested by funds: $179M → $182M (+$3.13M)
0.08% more ownership
Funds ownership: 66.6% → 66.68% (+0.08%)
3% less funds holding
Funds holding: 76 → 74 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.92M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.43M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.1M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$726K |
| 5 |
State Street
Boston,
Massachusetts
|
+$676K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$6.72M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$432K |
| 3 |
Millennium Management
New York
|
-$358K |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$347K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$316K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIM
76
Acrospire Investment Management
Chicago,
Illinois
| – | -$139K | -1,919 | Closed |
|
|
PAM
77
Panagora Asset Management
Boston,
Massachusetts
| – | -$34K | -469 | Closed |
|
78
Creative Planning
Overland Park,
Kansas
| – | -$33K | -450 | Closed |
|
UTMD Hedge Fund Activity: Q3 2017 in Review
74 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2017, worth a combined $182M — up 1.7% from $179M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of UTMD and 2 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 35 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.92M. The largest seller was American Century Companies, cutting an estimated $6.72M.
- 74 institutional investors held Utah Medical Products (UTMD) as of Q3 2017, down from 76 in Q2 2017.
- Funds reported $182M of Utah Medical Products stock for Q3 2017, up 1.7% quarter-over-quarter.
- 2 funds opened new Utah Medical Products positions in Q3 2017 and 4 closed out, a net change of -2 holders.
- The largest Utah Medical Products buyer in Q3 2017 was Renaissance Technologies, an estimated $1.92M added.
- The largest Utah Medical Products seller in Q3 2017 was American Century Companies, an estimated $6.72M sold.
Based on aggregated 13F filings for Q3 2017.